Welcome to our dedicated page for Danaher Corporation SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Danaher Corporation (NYSE: DHR) SEC filings page provides access to the company’s official regulatory documents filed with the U.S. Securities and Exchange Commission. These filings include current reports on Form 8‑K, quarterly reports on Form 10‑Q and other disclosures that detail Danaher’s financial performance, governance changes and capital markets activities as a global life sciences and diagnostics innovator.
Danaher uses Form 8‑K filings to report material events such as quarterly and annual financial results, estimated financial performance ahead of investor conferences, amendments to its by‑laws, share repurchase authorizations and changes in senior leadership or board composition. For example, the company has filed 8‑Ks to furnish earnings press releases and presentation slides, to describe updates to its by‑laws regarding shareholder proposal and nomination procedures, and to outline a share repurchase program authorizing the repurchase of up to 35 million shares of common stock.
The filings also list Danaher’s securities registered under Section 12(b) of the Exchange Act, including its common stock and multiple series of senior notes with various maturities, all traded on the New York Stock Exchange. This information helps investors understand the company’s capital structure and the instruments available in public markets.
Through its periodic reports, Danaher provides detailed financial statements, management’s discussion and analysis, and explanations of non‑GAAP measures such as core sales growth and adjusted diluted net earnings per common share. The company explains how it calculates these measures, why management uses them and how they reconcile to the most directly comparable GAAP figures, including adjustments for amortization of acquisition‑related intangible assets, fair value gains and losses on investments, impairments and tax effects.
On Stock Titan, users can review these SEC filings alongside AI‑powered summaries that highlight key points, such as revenue trends, margin drivers, capital allocation decisions, governance changes and risk disclosures. The platform’s tools can help readers quickly understand the implications of Danaher’s 10‑Q and 10‑K reports, as well as 8‑K items related to dividends, share repurchases, executive transitions and by‑law amendments, while still allowing detailed review of the original documents.
Danaher Corp: The Vanguard Group amends Schedule 13G to report no beneficial ownership. The filing states that after an internal realignment on January 12, 2026, certain Vanguard subsidiaries now report holdings separately and The Vanguard Group reports 0 shares and 0% beneficial ownership of Danaher common stock.
The filing explains the change is in accordance with SEC Release No. 34-39538 and is an administrative reallocation of reporting responsibilities within Vanguard; it does not describe purchases, sales, or cash flows in this excerpt.
Danaher Corporation reported 2025 continuing-operations results and presented its 2026 strategic priorities. Revenue was $24.6 billion, with $5.3 billion of free cash flow and adjusted diluted EPS of $7.80 (non-GAAP). The company generated 2% core revenue growth and 4.5% adjusted EPS growth year over year.
Management highlighted portfolio innovation across Biotechnology, Life Sciences and Diagnostics, continued deployment of the Danaher Business System and a bias to disciplined M&A, while noting risks including regulatory, geopolitical, competitive and reimbursement pressures.
Danaher Corporation is asking shareholders to elect eleven directors, ratify Ernst & Young LLP, approve an advisory vote on executive pay and approve an amended Omnibus Incentive Plan at its virtual 2026 annual meeting. The company highlights 2025 sales of $24.6 billion, operating profit of $4.7 billion and operating cash flow of $6.4 billion, supported by about $1.6 billion in research and development and $1.2 billion in capital expenditures.
Danaher also returned approximately $4.0 billion to shareholders through buybacks and dividends and agreed in February 2026 to acquire Masimo Corporation for about $9.9 billion in cash, including assumed debt and net of acquired cash, subject to regulatory and Masimo shareholder approvals. The proxy emphasizes a majority‑independent board with separate Chairman and CEO roles, majority voting for directors, proxy access, a 25% special meeting right and extensive compensation governance features such as clawbacks, robust stock ownership requirements and long-term, performance-based equity incentives.
Danaher Corp. notified the NYSE to remove a class of securities from listing. The Form 25 identifies the class as the guarantor of the 0.200% Senior Notes due 2026. The Exchange and the issuer state they complied with the procedures in 17 CFR 240.12d2-2 for voluntary withdrawal.
Leiken Jonathan reported acquisition or exercise transactions in this Form 4 filing.
Danaher Corporation reported that SVP and Chief Legal Officer Jonathan Leiken received new equity awards. On March 1, 2026 he was granted 6,416 employee stock options at a price of $0.00 per share and 2,374 shares of common stock via restricted stock units. The RSUs vest 25% on each of the first four anniversaries of the March 1, 2026 grant date, while 50% of the options become exercisable on each of the third and fourth anniversaries of that grant date.
McGrew Matthew reported acquisition or exercise transactions in this Form 4 filing.
Danaher Corporation Executive Vice President Matthew McGrew received new equity awards on March 1, 2026. He was granted employee stock options for 16,039 shares at a grant price of $0.00 per share and a separate award of 5,935 shares of common stock, reported as restricted stock units (RSUs).
According to the disclosures, fifty percent of the options become exercisable on each of the third and fourth anniversaries of the March 1, 2026 grant date. For the RSUs, twenty-five percent vest on each of the first four anniversaries of the same grant date, creating a four-year vesting schedule tied to continued service.
Danaher Corporation Executive Vice President Gregory M. Milosevich reported new equity awards and a related tax share disposition. He received an employee stock option grant covering 11,548 shares at a grant price of $0.0000 per share and 4,273 restricted stock units payable in common stock. In connection with the RSU award, 118 common shares at $210.64 per share were withheld to cover tax obligations, leaving him with 9,065 directly held common shares and 11,548 options. The RSUs vest in four equal annual installments starting on March 1, 2026, and the options become exercisable in two equal installments on the third and fourth anniversaries of that grant date.
Danaher Corporation executive Christopher Bouda reported new equity awards and related tax withholding. On March 1, 2026, he acquired 3,369 employee stock options and 1,247 restricted stock units payable in common stock, both granted at a price of $0.00 per share.
According to the filing, 25% of both the RSUs and options vest on each of the first four anniversaries of the March 1, 2026 grant date. To cover tax obligations, 170 shares of common stock were disposed of at $210.64 per share. After these transactions, Bouda directly holds 9,167 common shares and indirectly holds 677.227 shares through a 401(k) plan.
Danaher Corporation reported equity awards for SVP and Chief Science Officer Jose-Carlos Gutierrez-Ramos. He received 17,964 employee stock options and 6,647 shares of common stock as a grant on March 1, 2026. The footnotes state that 25% of the restricted stock units vest on each of the first four anniversaries of the grant date, and 50% of the options become exercisable on each of the third and fourth anniversaries. In a related tax-withholding transaction, 284 shares of common stock were disposed of at $210.64 per share, leaving him with 19,018 common shares directly owned after these transactions.
Danaher Corporation Executive Vice President Christopher Paul Riley reported equity awards and related tax withholding. On March 1, 2026, he received an employee stock option covering 16,681 shares at an exercise price of $0.00 per share and a grant of 6,172 shares of common stock in the form of restricted stock units. According to the filing, 25% of the RSUs vest on each of the first four anniversaries of the March 1, 2026 grant date, and 50% of the options become exercisable on each of the third and fourth anniversaries of that date. The report also shows 1,115 shares of common stock disposed of at $210.64 per share to satisfy tax withholding obligations, leaving him with 20,400 common shares directly owned after these transactions.